Consolidated Statement Of Comprehensive Income

Carna Biosciences, Inc. - Filing #7313273

Concept 2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
Consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
-1,094,118,000 JPY
-885,608,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-425,000 JPY
-340,000 JPY
Deferred gains or losses on hedges
27,374,000 JPY
-615,000 JPY
Foreign currency translation adjustment
40,699,000 JPY
25,174,000 JPY
Other comprehensive income
67,649,000 JPY
24,217,000 JPY
Comprehensive income
-1,026,469,000 JPY
-861,390,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-1,026,469,000 JPY
-861,390,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.